Online ordering is open. Ships in 1 to 2 business days. Tracked 2-day shipping, plain box. Every compound third-party tested

For laboratory and research use only. Not for human or veterinary use.

Cartalax

1
size
HPLC
purity, third-party tested
Cartalax vial
$65per vial

Identity

What Cartalax is

Cartalax is a branded name put on a very short synthetic peptide, just three amino acids long: alanine, glutamic acid, and aspartic acid, often written as AED. It comes out of a Russian research program that spent decades making short peptides loosely modeled on natural signals found in body tissues, in Cartalax's case, cartilage. The idea is that a tiny fragment might nudge a specific tissue's cells the way a single word can shift the tone of a sentence, without needing the whole original protein.

Cartalax is a laboratory reference material. SBz Industries sells it for laboratory research.

Available sizes
20 mg

Research

What the research has looked at

In plain terms, with a link to every study. The most useful thing to notice is what each study was done in.

Published research specific to the AED peptide behind Cartalax is limited to laboratory cell-culture work, done by the same St. Petersburg-based research group that developed it, alongside several other short peptides from the same family. No study of AED, or of Cartalax as a branded product, in live animals or in people turned up in our search.

cells2016

Researchers grew human skin cells called fibroblasts in dishes until they showed signs of cell aging, then added several short peptides, including AED, to the cultures. Cells treated with AED showed less activity in the enzyme that breaks down the cell's structural scaffolding, more cell division, and fewer signs of the programmed cell death that becomes more common as cells age.

Peptide Regulation of Skin Fibroblast Functions during Their Aging In Vitro.
Lin'kova and colleagues, Bulletin of Experimental Biology and Medicine

cells2020

Human bone-marrow stem cells grown in the lab until they aged in culture were treated with three short peptides, including AED, and researchers measured activity of five genes linked to cell aging and growth. AED was one of three peptides that increased activity of a gene called IGF1, along with changes in a handful of other aging-related genes, though the exact pattern shifted depending on how the cells had been aged.

Gene expression in human mesenchymal stem cell aging cultures: modulation by short peptides.
Ashapkin and colleagues, Molecular Biology Reports

Each study links to its record on PubMed, the US National Library of Medicine database. Checked 25 September 2026.

Handling

Mixing and storage

Full handling guide
  1. 01

    Let it warm up

    Give the vial twenty minutes on the bench before opening it, so water does not condense onto the powder.

  2. 02

    Add bacteriostatic water

    Slowly, down the inside wall of the vial, never straight onto the powder.

  3. 03

    Let it dissolve

    Leave it alone until it clears. Do not shake it. Shaking damages the peptide.

  4. 04

    Refrigerate and use

    Once mixed, it breaks down much faster than the dry powder. Keep it cold and dark.

Documentation

Tested before it goes on sale

An independent lab tests every compound we sell. It confirms the compound is what the label says and measures purity by HPLC.

The latest certificate is on the product page, so you can read the result before you order.

See the certificate

Questions

Common questions about Cartalax

What is Cartalax?

Cartalax is a branded name put on a very short synthetic peptide, just three amino acids long: alanine, glutamic acid, and aspartic acid, often written as AED. It comes out of a Russian research program that spent decades making short peptides loosely modeled on natural signals found in body tissues, in Cartalax's case, cartilage. The idea is that a tiny fragment might nudge a specific tissue's cells the way a single word can shift the tone of a sentence, without needing the whole original protein. SBz Industries sells it for laboratory research only.

Is Cartalax the same as the peptide AED?

Cartalax is a brand name; AED (Ala-Glu-Asp) is the three-amino-acid peptide behind it. The published research is on the AED peptide itself, done by the lab that developed it, not on a product called Cartalax specifically.

Has Cartalax been tested in cartilage tissue?

Not in any published study we could find. Despite the cartilage-linked name and origin, the available cell-culture research has actually looked at skin cells and bone-marrow stem cells, not cartilage cells.

How is Cartalax reconstituted?

Cartalax ships as a freeze-dried powder. Mix it with bacteriostatic water, added slowly down the inside wall of the vial, and let it dissolve without shaking. The researcher decides the working concentration, not us, and we publish no protocols.

How should Cartalax be stored?

Store as stated on the product page and the certificate of analysis. Vials ship in plain outer packaging with no product name on the outside.

Is Cartalax tested, and can I see the results?

Yes. An independent lab tests every compound: it confirms the compound is what the label says and measures purity by HPLC. The latest certificate is on the product page, and you can read it before you order.

Who is permitted to purchase Cartalax?

Researchers and institutions, 21 or over. By ordering you confirm the material is for laboratory research and will not be used in humans or animals.

Order

Cartalax, third-party tested

Every compound is third-party tested, with the certificate on its product page. Every order ships in plain packaging.

Fast dispatchShips in 1 to 2 business days
Plain packagingNo exterior branding
Tracked shippingTwo business days, flat rate
Third-party testedCertificate on every product page